As IQVIA previously owned the majority share of the joint venture, it has consolidated 100 percent of Q2 Solutions revenue and Adjusted EBITDA into its reported financial statements. Learn more at www.iqvia.com. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow. Cancer Center Support Services, Inteliquet, an IQVIA Company. IQVIA Inc. Inteliquet Business Development/Sales Director Job in Remote List of IQVIA 's 8 Acquisitions, including Pharmaspectra and Linguamatics. IQVIA Holdings Inc. - IQVIA Reports Fourth-Quarter and Full-Year 2018 IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. At Inteliquet an IQVIA business, we believe every patient is valuable and worthy of our very best efforts. Inteliquet Jun 16, 2021, 06:00 ET DOVER, Del., June 16, 2021 /PRNewswire/ -- Inteliquet announced today Comprehensive Hematology and Oncology, LLC (CHO) of St. Petersburg, Florida will join. Inteliquet, an IQVIA business, is a leading provider of oncology solutions and insights on a mission to transform the accessibility, usability, and limitless possibilities of cancer research and real-world evidence. We bridge sponsors, patients and cancer centers nationwide for the ultimate purpose of increasing patient access to cancer trial . With AI-enhanced technology and expert support services, Inteliquet offers a comprehensive solution to transform the patient enrollment journey. All rights reserved. Find out whats going on right here, right now. Thank you. Learn more. The company offers clinical trial patient screening and enrollment, site selection and CRO (contract research organization) bid and proposal services, helping CROs and healthcare . 273 IQVIA Site Acquisition Specialist jobs. It is like it was built especially for me., Your ability to facilitate a liaison with CROs and Providers builds more productive connections of trials., We understand our patient population so much better. The Life Sciences Sector Deal announced by the UK Government last year was a major step forward for the . Cautionary Statements Regarding Forward-Looking Statements. Head of Marketing & Communications, Inteliquet - emplois.iqvia.com . IQVIA Acquires Remaining Interest in Q Solutions from Quest Diagnostics Raises Full Year 2021 Adjust, https://www.businesswire.com/news/home/20210401005191/en/. Artificial intelligence is accelerating opportunities. The company offers clinical trial patient screening and enrollment, site selection and CRO (contract research organization) bid and proposal services, helping CROs and healthcare providers improve the accuracy of time estimations for patient enrollment, increase patient accrual rates and improve patient outcomes. Together, we can solve customer challenges and improve patient lives. Business development jobs in Eddystone, PA - Jooble For a further discussion of the risks relating to the combined companys business, see the Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2020, filed with the SEC, as such factors may be amended or updated from time to time in our subsequent periodic and other filings with the SEC, which are accessible on the SECs website at www.sec.gov. IQVIA Connected Intelligence delivers powerful insights with speed and agility enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. Non-GAAP financial information is provided to enhance understanding of the companys financial performance, but none of these non-GAAP financial measures are recognized terms under GAAP, and non-GAAP measures should not be considered in isolation from, or as a substitute analysis for, the companys results of operations as determined in accordance with GAAP. ACRPs DEI Statement & Guiding Principles - Diversity, equity, and inclusion are essential values to the success of ACRP. IQVIA - Wikipedia The Company's most targeted sectors include life science (48%) and business . We harness vast sets of oncology and patient data to bring a new level of clarity to the process and . DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the acquisition of the 40 percent minority share of Q 2 Solutions from Quest Diagnostics (NYSE: DGX), the world leader in diagnostic . Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners. United States, IQVIA Reports Third-Quarter 2022 Results. Get the full list, Youre viewing 4 of 9 executive team members. Through the power of natural language processing and proprietary data parsers, OncWeb harnesses unstructured clinical data beyond the EMR, including biomarker reports, so more complete patient matching is achieved. Chief Medical Officer & Strategic Medical Advisor, Youre viewing 2 of 25 competitors. (919) 998-2000 Faster decision making and reduced risk so you can deliver life-changing therapies faster. IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry dedicated to creating intelligent connections that deliver unique innovations and actionable insights. October 26, 2022. Harness unparalleled data to answer complex questions and uncover new possibilities. This session is presented by Inteliquet Discover how clinical trials as a treatment option has moved beyond vision with the integration of legacy medical systems and content, and new practices such as biomarker parsing and decentralized trials. IQVIA, Inc. provides reasonable accommodations for applicants with disabilities. Pricing. List of IQVIA's 8 Acquisitions, including Pharmaspectra And In recent market research with senior Life . 847 IQVIA Senior Talent Acquisition Executive jobs. Connecting unparalleled data, advanced analytics, innovative technologies, and deep healthcare and scientific expertise makes it possible for our customers to discover previously unseen insights, smarter decision-making, and unleash new opportunities. Seoul, South Korea | R1322580. Search job openings, see if they fit - company salaries, reviews, and more posted by IQVIA employees. View job listing details and apply now. . 27703 IQVIA Mergers and Acquisitions Summary | Mergr We bridge sponsors, patients and cancer centers nationwide for the ultimate purpose of increasing patient access to cancer trial . Durham, North Carolina Decision-makers must also review individual case safety reports (ICSRs) exchange conditions. At Inteliquet, an IQVIA Business, we're on a mission to transform the patient enrollment journey through modern technology and expertise. Participate in Inteliquet leadership team meetings, participation and engagement with IQVIA GTM teams both at GBU and RBU levels, and other meetings as needed. Please use this form to reach out to our media team with inquiries. Envisioning a world where everyone has timely access to the best and longest-lasting . Free, fast and easy way find a job of 769.000+ postings in Eddystone, PA and other big cities in USA. Full-Time. Developer of healthcare analytical tools intended to transform the accessibility, usability and possibilities of cancer research and real-world evidence. Improving human health requires brave thinkers who are willing to explore new ideas, build on successes, and learn from mistakes. Competitive salary. At Inteliquet an IQVIA business, we believe every patient is valuable and worthy of our very best efforts. Resources. The result? We are pleased to speak with you during our standard business hours. Seoul Jobs at IQVIA Search our Job Opportunities at IQVIA IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. Contact Email inteliquet@iqvia.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20210401005191/en/, Andrew Markwick, IQVIA Investor Relations (andrew.markwick@iqvia.com) +1.973.257.7144, Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com) +1.484.567.6732. 4820 Emperor Blvd Durham, NC 27703-8426 . Jeanie Magdalena Gatewood, Managing Director, Cancer Center Support Services of Inteliquet, an IQVIA business will be presenting at The Conference Forum's #CRAACO2022 Conference. Products & Services Categories. Life at IQVIA. Head of Marketing & Communications, Inteliquet at IQVIA North Carolina Life Science with Acquisitions, North Carolina Life Science with Divestitures, Recently Acquired North Carolina Companies, Recently Acquired United States Companies, M&A research that takes seconds (not all afternoon), Better understand your customers and prospects. Applicants who require reasonable accommodation to submit an application for employment or otherwise participate in the application process should contact IQVIA's Talent Acquisition team at [email protected] to arrange for such an accommodation. Tim Sheppard, Senior Vice President (SVP) and General Manager, Northern Europe IQVIA, said: "This landmark investment package is a demonstration of IQVIA's confidence in, and its commitment to, the future of the UK life sciences industry. IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research.IQVIA is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services. IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Inteliquet, an IQVIA business on LinkedIn: Spotlight: Bruce M. Wakeman Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence. Headquarters Regions Southern US. Realizing the benefits for healthcare requires the right expertise. IQVIA has acquired in 10 different US states, and 2 countries. www.iqvia.com. Where human science and data science meet, the possibilities are endless. Inteliquet Company Profile: Acquisition & Investors | PitchBook We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them. Get in touch today to discover the right solutions for you. Phone: 866.267.4479 . Inteliquet, an IQVIA business | LinkedIn In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as expect, assume, anticipate, intend, plan, forecast, believe, seek, see, will, would, target, similar expressions, and variations or negatives of these words. Our mission is to accelerate innovation for a healthier world. Explore Opportunities. Verified employers. Full-time, temporary, and part-time jobs. Clinical Trials Assistant / Senior Clinical Trials Assistant. Unleash your potential with us. Non-GAAP measures are not necessarily comparable to similarly titled measures used by other companies. The Association of Clinical Research Professionals (ACRP) supports clinical research professionals through membership, training and development, and certification. February 14, 2019. . Work is non-routine and very complex, involving the application of advanced technical/business skills in the area of specialization. Copyright 2022 Inteliquet, an IQVIA business. Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone. The transaction is expected to be approximately $0.12 accretive to IQVIAs 2021 Adjusted Diluted EPS and at least $0.18 accretive to 2022 Adjusted Diluted EPS. Actual results may differ materially from our expectations due to a number of factors, including, but not limited to, the following: business disruptions caused by natural disasters, pandemics such as the COVID-19 (coronavirus) outbreak and the public health policy responses to the outbreak, international conflicts or other disruptions outside of our control; our ability to accurately model or forecast the impact of the spread and/or containment of COVID-19, among other sources of business interruption, on our operations and financial results; most of our contracts may be terminated on short notice, and we may lose or experience delays with large client contracts or be unable to enter into new contracts; the market for our services may not grow as we expect; we may be unable to successfully develop and market new services or enter new markets; imposition of restrictions on our use of data by data suppliers or their refusal to license data to us; any failure by us to comply with contractual, regulatory or ethical requirements under our contracts, including current or changes to data protection and privacy laws; breaches or misuse of our or our outsourcing partners security or communications systems; failure to meet our productivity or business transformation objectives; failure to successfully invest in growth opportunities; our ability to protect our intellectual property rights and our susceptibility to claims by others that we are infringing on their intellectual property rights; the expiration or inability to acquire third party licenses for technology or intellectual property; any failure by us to accurately and timely price and formulate cost estimates for contracts, or to document change orders; hardware and software failures, delays in the operation of our computer and communications systems or the failure to implement system enhancements; the rate at which our backlog converts to revenue; our ability to acquire, develop and implement technology necessary for our business; consolidation in the industries in which our clients operate; risks related to client or therapeutic concentration; government regulators or our customers may limit the scope of prescription or withdraw products from the market, and government regulators may impose new regulatory requirements or may adopt new regulations affecting the biopharmaceutical industry; the risks associated with operating on a global basis, including currency or exchange rate fluctuations and legal compliance, including anti-corruption laws; risks related to changes in accounting standards; general economic conditions in the markets in which we operate, including financial market conditions and risks related to sales to government entities; the impact of changes in tax laws and regulations; our ability to successfully integrate, and achieve expected benefits from, our acquired businesses; and risks and uncertainty associated with providing guidance and forecasts earlier than is our customary practice. The company uses non-GAAP measures in its operational and financial decision making, and believes that it is useful to exclude certain items in order to focus on what it regards to be a more meaningful indicator of the underlying operating performance of the business. Sorry, we couldnt find that page. Solutions. CHICAGO Inteliquent, the largest independent voice communications provider in the United States, today entered into a definitive agreement to be acquired by Sinch AB (publ) - XSTO: SINCH, a global leader in cloud communications for mobile customer engagement, for a total cash consideration of $1.140B USD. Inteliquet Business Development/Sales Director - IQVIA | Built In Search Crunchbase. IQVIA hiring Associate Strategic Operations Director in Reading PDF Insight Brief Mergers and Acquisitions - IQVIA Inteliquet Announces Comprehensive Hematology And Oncology To Join Companies Contacts Investors Funding Rounds Acquisitions People Events Schools Hubs Saved . Find out how. Lead the way in machine learning, artificial intelligence and advanced analytics for the healthcare industry. Find out what's happening right here, right now. When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap. Director of strategic sourcing jobs in Reading, PA As Talent Acquisition Business Partner at IQVIA I am responsible for hiring candidates for the range of Leadership roles across Europe (circa 200 - 250 filled positions per year). Get the full list. Inteliquet, an IQVIA business' Post. IQVIAs largest acquisition to date was in 2016, when it acquired IMS Health Holdings for $8.8B. The Companys most targeted sectors include life science (48%) and business services (24%). Applicants who require reasonable accommodation to submit an application for employment or otherwise participate in the application process should contact IQVIA's Talent Acquisition team at workday_recruiting@iqvia.com to arrange for such an accommodation. We're pleased to speak with you during our business hours. Search job openings, see if they fit - company salaries, reviews, and more posted by IQVIA employees. They must also assign responsibilities for overseeing aggregate safety The transaction has been financed through cash on hand and is not expected to impact IQVIAs target net leverage ratio. Non-GAAP measures are frequently used by securities analysts, investors and other interested parties in their evaluation of companies comparable to the company, many of which present non-GAAP measures when reporting their results. Transforming the Patient Enrollment Journey | Inteliquet, an IQVIA business, Inteliquet is a leading provider of innovative technology and comprehensive support services for cancer clinical researchers. Sinch establishes leadership in U.S. voice communications by acquiring They are not presentations made in accordance with GAAP, are not measures of financial condition or liquidity and should not be considered as an alternative to profit or loss for the period determined in accordance with GAAP or operating cash flows determined in accordance with GAAP. acquisition negotiations, decision-makers must define which party will hold and maintain that database to assure compliance continuity. Products. Inteliquent to Be Acquired by Sinch | Inteliquent IQVIA Site Acquisition Specialist Jobs | Glassdoor 9 years in the pharmaceutical, CRO, or related industry, experience to include clinical . Non-GAAP measures are frequently used by . Inteliquet, an IQVIA business on LinkedIn: #CRAACO2022 #HealthTech # IQVIA is a provider of advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. We assume no obligation to update any such forward-looking statement after the date of this release, whether as a result of new information, future developments or otherwise.